Alan Sebulsky, Director at Parabilis Medicines, Inc. (PBLS), bought 17,500 shares at $27.67 ($474K) on 2026-06-12, disclosed to the SEC on 2026-06-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.67 | 8,435 | $233K | 49.3% |
| 2 | $26.00 | 5,000 | $130K | 27.5% |
| 3 | $27.10 | 4,065 | $110K | 23.3% |
| Total | $27.06 avg | 17,500 | $474K | 100% |
| Filing → |
| JAZZ | BUY | 2009-11-17 | $67K | — | Filing → |
| JAZZ | BUY | 2007-06-08 | $90K | — | Filing → |
| ARRO | SELL | 2006-04-17 | $305K | — | Filing → |